CEA in breast ductal secretions as a promising biomarker for the diagnosis of breast cancer: a systematic review and meta-analysis

Breast Cancer : the Journal of the Japanese Breast Cancer Society
Shifu TangJianqing Yang

Abstract

Other studies have shown that levels of carcinoembryonic antigen (CEA) in breast ductal secretions (BDS) differ significantly between breast cancer (BC) patients and healthy individuals, providing direct evidence for CEA in BDS as a promising biomarker for BC. This meta-analysis was designed to assess the potential diagnostic value of CEA in BDS. Relevant articles were retrieved from Embase, Pubmed, and the Cochrane Library. Sensitivity, specificity, and diagnostic odds ratio (DOR) of CEA in BDS for diagnosing BC were pooled using random effects models. SROC and the area under the curve (AUC) were used to estimate overall diagnostic performance. This meta-analysis comprised five studies with a total of 340 BC patients and 448 healthy controls. For CEA in BDS, the pooled sensitivity, specificity, and DOR to diagnose BC were 58 % [95 % confidence interval (CI): 52-63 %], 87 % (95 % CI: 84-90 %), and 7.07 (95 % CI: 3.10-16.12), respectively. Moreover, the AUC of CEA in the diagnosis of BC was 0.8570. CEA in BDS is a promising biomarker in the diagnosis of BC and should be evaluated as a standard screening tool upon verification of our results in a larger study population.

References

Sep 1, 1965·The Journal of Experimental Medicine·P Gold, S O Freedman
Jan 1, 1993·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·H InajiH Ohkura
Mar 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Y ZhaoF P Li
Nov 15, 2003·Journal of Clinical Epidemiology·Afina S GlasPatrick M M Bossuyt
Dec 29, 2004·The Annals of Thoracic Surgery·Catherine M Jones, Thanos Athanasiou
Jul 14, 2006·BMC Medical Research Methodology·Javier ZamoraArri Coomarasamy
Feb 13, 2009·Expert Review of Proteomics·Ferdinando MannelloGaetana A Tonti
Mar 11, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ya-Shuang ZhaoHong-yuan Li
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Oct 19, 2011·Annals of Internal Medicine·Penny F WhitingUNKNOWN QUADAS-2 Group
Nov 22, 2011·Lancet·Monica MorrowElizabeth Morris
Mar 13, 2012·Cancer Science·Miki OdaOsamu Matsubara
Nov 23, 2012·The New England Journal of Medicine·Archie Bleyer, H Gilbert Welch
Nov 6, 2013·Archives of Gynecology and Obstetrics·Manfred KaufmannSibylle Loibl
May 30, 2014·The Lancet Oncology·Lei FanPaul E Goss
Jun 1, 2014·International Journal of Molecular Sciences·Gangping WangYanqing Sun
Jul 19, 2014·Clinical Breast Cancer·Hanan Gewefel, Bodour Salhia
Mar 21, 2015·AJR. American Journal of Roentgenology·Jessica M EngelAdedayo A Onitilo
May 1, 2015·Breast Cancer Research : BCR·Magnus LøbergMette Kalager

❮ Previous
Next ❯

Citations

Nov 23, 2018·Naunyn-Schmiedeberg's Archives of Pharmacology·Amira SalehWaleed Barakat
May 11, 2018·Journal of Korean Neurosurgical Society·Orli Michaeli, Uri Tabori
Oct 31, 2019·Veterinary and Comparative Oncology·Igor L S SenhorelloMirela Tinucci-Costa
Jan 3, 2020·Clinical and Experimental Medicine·Ya GaoUNKNOWN Cancer Biomarker Assessment Working Group
Aug 17, 2018·Experimental and Therapeutic Medicine·Dena KeLina Jing
Jan 9, 2019·Frontiers in Oncology·Liyuan JiaJihong Cui
Dec 26, 2018·Gastroenterology Research and Practice·Haibo XingDa Li
Jan 1, 2021·Frontiers in Oncology·Mariela Montaño-SamaniegoMiguel Ibáñez-Hernández
Apr 27, 2021·Laboratory Medicine·Jose Antonio DelgadoJosep Miquel Bauça
May 15, 2021·Frontiers in Pharmacology·Hanyi FangBernadette Marquez-Nostra
Aug 25, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Suliman KhanTimo L M Ten Hagen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Yong WangYaqun Zhao
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Qinfeng YangDequan Zhu
International Journal of Clinical and Experimental Medicine
Mingxia DingChong Li
© 2022 Meta ULC. All rights reserved